Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

IMPORTANCE: Use of next-generation sequencing (NGS) to identify clinically actionable genomic targets has been incorporated into routine clinical practice in the management of advanced solid tumors; however, the clinical utility of this testing remains uncertain. OBJECTIVE: To determine which patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobain, Erin F., Wu, Yi-Mi, Vats, Pankaj, Chugh, Rashmi, Worden, Francis, Smith, David C., Schuetze, Scott M., Zalupski, Mark M., Sahai, Vaibhav, Alva, Ajjai, Schott, Anne F., Caram, Megan E. V., Hayes, Daniel F., Stoffel, Elena M., Jacobs, Michelle F., Kumar-Sinha, Chandan, Cao, Xuhong, Wang, Rui, Lucas, David, Ning, Yu, Rabban, Erica, Bell, Janice, Camelo-Piragua, Sandra, Udager, Aaron M., Cieslik, Marcin, Lonigro, Robert J., Kunju, Lakshmi P., Robinson, Dan R., Talpaz, Moshe, Chinnaiyan, Arul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907987/
https://www.ncbi.nlm.nih.gov/pubmed/33630025
http://dx.doi.org/10.1001/jamaoncol.2020.7987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907987/
https://www.ncbi.nlm.nih.gov/pubmed/33630025
http://dx.doi.org/10.1001/jamaoncol.2020.7987

Ejemplares similares